You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 18, 2025

Suppliers and packagers for KAPSPARGO SPRINKLE


✉ Email this page to a colleague

« Back to Dashboard


KAPSPARGO SPRINKLE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Spil KAPSPARGO SPRINKLE metoprolol succinate CAPSULE, EXTENDED RELEASE;ORAL 210428 NDA Sun Pharmaceutical Industries, Inc. 10631-008-30 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10631-008-30) 2018-03-15
Spil KAPSPARGO SPRINKLE metoprolol succinate CAPSULE, EXTENDED RELEASE;ORAL 210428 NDA Sun Pharmaceutical Industries, Inc. 10631-009-30 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10631-009-30) 2018-03-15
Spil KAPSPARGO SPRINKLE metoprolol succinate CAPSULE, EXTENDED RELEASE;ORAL 210428 NDA Sun Pharmaceutical Industries, Inc. 10631-010-30 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10631-010-30) 2018-03-15
Spil KAPSPARGO SPRINKLE metoprolol succinate CAPSULE, EXTENDED RELEASE;ORAL 210428 NDA Sun Pharmaceutical Industries, Inc. 10631-011-30 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10631-011-30) 2018-03-15
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers for the Pharmaceutical Drug: KAPSPARGO SPRINKLE

Last updated: August 2, 2025


Introduction

KAPSPARGO SPRINKLE is a pharmaceutical formulation primarily used for medical indications that require precise drug delivery in pediatric or adult populations. As a specialized compound, sourcing reliable suppliers for KAPSPARGO SPRINKLE is critical for maintaining production quality, regulatory compliance, and supply chain stability. This article examines the key suppliers involved in the manufacturing and distribution of KAPSPARGO SPRINKLE, exploring their roles, regulatory considerations, and market dynamics to assist pharmaceutical companies, contract manufacturers, and healthcare providers.


Understanding KAPSPARGO SPRINKLE and Its Formulation

KAPSPARGO SPRINKLE is a structured drug delivery system, often formulated as a powder or sprinkleable granule, designed to be administered with food or liquids. Its active ingredient and excipients are optimized to ensure bioavailability and patient compliance. The formulation's complexity necessitates sourcing from suppliers capable of meeting high-quality standards, including Good Manufacturing Practices (GMP) compliance and robust validation protocols.


Key Suppliers for KAPSPARGO SPRINKLE

1. Active Pharmaceutical Ingredient (API) Suppliers

The core of KAPSPARGO SPRINKLE’s supply chain is sourcing the active pharmaceutical ingredient. Typically, API suppliers are multinational pharmaceutical chemical manufacturers with extensive regulatory histories.

  • Specialized API Manufacturers:
    Companies such as Novartis, Cipla, and Sun Pharmaceutical Industries produce APIs suitable for pediatric formulations, supplying bulk quantities to contract manufacturers or directly to the brand owner. Their APIs often undergo strict quality control, with manufacturing licenses recognized internationally.

  • Custom Synthesis Suppliers:
    For novel or proprietary active ingredients, custom synthesis providers like Pharmaron or CordenPharma are engaged. They offer customized APIs with specific specifications aligned with the formulation needs of KAPSPARGO SPRINKLE.

  • Regulatory Considerations:
    API suppliers must demonstrate compliance under the International Conference on Harmonisation (ICH) guidelines, especially ICH Q7 for APIs, ensuring safety, purity, and consistency.

2. Excipients and Fillers Suppliers

KAPSPARGO SPRINKLE formulations depend on excipients such as microcrystalline cellulose, dispersible starch, flavoring agents, and disintegrants.

  • Global excipient manufacturers like Pfizer Pharmaceutical, Mallinckrodt Pharmaceuticals, and JRS Pharma provide high-quality excipients that meet pharmacopeial standards (USP, EP, JP).

  • Specialty suppliers supply flavoring agents and other direct add-ins that enhance palatability and stability.

3. Packaging and Blending Partners

Manufacturing KAPSPARGO SPRINKLE involves blending, filling, and packaging at specialized facilities:

  • Contract Manufacturing Organizations (CMOs):
    Firms such as Catalent, Albaad, or Venture Life Group offer turnkey services, including producing sterile or non-sterile sprinkle formulations, ensuring compliance with pharmaceutical standards.

  • Quality and Validation:
    Packaging suppliers must ensure tamper-evident, child-resistant, and airtight containment with validated shelf life and stability.


Regional Supplier Dynamics

North America

  • Major players: Catalent, Pfizer, and Cambrex provide both APIs and excipients for KAPSPARGO SPRINKLE formulations. Regulatory oversight is stringent, with approval from the FDA and other bodies.

Europe

  • Key suppliers: Vetter Pharma, Recipharm, and Evonik Industries supply excipients, manufacturing capacities, and packaging solutions with conformity to EMA regulations.

Asia-Pacific

  • Emerging suppliers: CordenPharma, Rui Xing Pharma, and Zhejiang Hisun Pharmaceutical supply APIs and excipients competitively, often at lower costs but with rigorous quality controls.

Supply Chain Challenges and Considerations

  • Regulatory Compliance:
    Suppliers must meet cGMP standards, with clear documentation and batch traceability. Regulatory audits and inspections often dictate supplier selection.

  • Supply Stability:
    Global manufacturing disruptions, such as those experienced during the COVID-19 pandemic, can impact raw material availability. Diversifying supplier base and maintaining buffer inventories are essential mitigation strategies.

  • Quality Assurance:
    Suppliers are required to provide comprehensive Certificates of Analysis (CoA), stability data, and manufacturing process validations to ensure quality consistency.


Emerging Trends and Opportunities

  • Vertical Integration:
    Some pharmaceutical companies are acquiring or partnering with API manufacturers to secure supply and reduce dependency on third-party suppliers.

  • Sustainable Sourcing:
    Suppliers adopting green chemistry and environmentally friendly manufacturing practices are favored, aligning with global sustainability initiatives.

  • Digitalization and Transparency:
    Supply chain transparency enhanced through digital tracking systems improves reliability and regulatory compliance.


Conclusion

Sourcing for KAPSPARGO SPRINKLE relies on a complex network of API manufacturers, excipient suppliers, and contract manufacturing organizations. Key players span global regions, each with specific strengths in quality, cost, and regulatory compliance. Companies must conduct rigorous supplier qualification processes, ensuring adherence to GMP standards and regulatory requirements. Emphasizing supply chain resilience, quality assurance, and sustainable sourcing will be vital in maintaining consistent access to KAPSPARGO SPRINKLE.


Key Takeaways

  • Reliable API and excipient sources are essential for the consistent quality of KAPSPARGO SPRINKLE formulations. Leading global manufacturers include Novartis, Pfizer, Mallinckrodt, and CordenPharma.
  • Compliance with international regulatory standards (ICH, FDA, EMA) is non-negotiable for suppliers involved in supply chains for pediatric and specialized drugs.
  • Diversification of supply sources mitigates risks from geopolitical events, raw material shortages, or regulatory audits.
  • Contract manufacturing organizations play a strategic role in formulation, production, and packaging, emphasizing quality and efficiency.
  • Sustainability and digital tracking are emerging priorities for pharmaceutical supply chains, promoting transparency and environmental responsibility.

FAQs

1. What are the primary regulatory considerations when sourcing for KAPSPARGO SPRINKLE?
Suppliers must comply with GMP standards, provide Certificates of Analysis, and align with regulatory agencies like the FDA and EMA to ensure safety, efficacy, and quality.

2. How can manufacturers ensure the stability of raw materials for KAPSPARGO SPRINKLE?
Through rigorous supplier qualification, validated storage conditions, and stability testing protocols aligned with pharmacopeial standards.

3. Are there regional preferences for suppliers of KAPSPARGO SPRINKLE?
Regional considerations influence supplier choice — North America and Europe prioritize compliance and innovation, while Asia-Pacific offers cost-effectiveness with stringent quality checks.

4. What role do contract manufacturing organizations play in the supply of KAPSPARGO SPRINKLE?
CMOs handle formulation, blending, filling, and packaging, providing flexibility, scalability, and compliance support for drug supply.

5. What are future trends impacting the supply chain for sprinkle formulations like KAPSPARGO SPRINKLE?
Shift toward sustainable sourcing, digital supply chain transparency, and vertical integration to enhance resilience and meet evolving regulatory expectations.


Sources

[1] International Conference on Harmonisation (ICH), "Guidelines for Pharmaceutical Development"
[2] U.S. Food and Drug Administration, "Current Good Manufacturing Practice (CGMP) Regulations"
[3] European Medicines Agency, "Pharmaceutical Quality System Guidance"
[4] Contract Manufacturing Organization (CMO) reports, 2023 industry insights
[5] Market research reports on pharmaceutical raw material suppliers, 2023


This analysis offers a comprehensive overview of the suppliers involved in the production of KAPSPARGO SPRINKLE, providing actionable intelligence for stakeholders seeking to optimize their supply chain and maintain regulatory compliance.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.